Circulating metabolomic profile can predict
dyslipidemia in HIV patients undergoing antiretroviral
therapy.
Rodríguez-Gallego E,
Gómez J, Domingo P, Ferrando-Martínez S, et al
Atherosclerosis.
2018 Apr 9;273:28-36.
Abstract
Influence of pharmacotherapy complexity on compliance with
the therapeutic objectives for HIV+ patients on
antiretroviral treatment concomitant with therapy for
dyslipidemia. INCOFAR Project.
Jiménez Galán R, Montes Escalante IM, Morillo Verdugo R.
Farm Hosp.
2016 Mar 1;40(n02):90-101.
Abstract
Impact of genetic factors on dyslipidemia in
HIV-infected patients starting antiretroviral therapy.
Egaña-Gorroño L, Martínez E, et al
AIDS. 2012 Dec 19..
Abstract
The distribution of Apolipoprotein E gene
polymorphism and their influences in dyslipidemias in HIV-1
infections.
Suwalak T, Srisawasdi P, Puangpetch A, et al
Jpn J Infect Dis.
2014 Nov 25.
Abstract
FULL-TEXT ARTICLE
Erectile Dysfunction Among HIV Patients Undergoing Highly
Active Antiretroviral Therapy: Dyslipidemia as a Main Risk
Factor.
Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI,
et al
Sex Med.
2014 Apr;2(1):24-30
Paper
FULL-TEXT ARTICLE
Antiretroviral treatment associated hyperglycemia and
dyslipidemia among HIV infected
patients at Burayu Health Center, Addis Ababa, Ethiopia: a
cross-sectional comparative study.
Abebe M, Kinde S, Belay G, et al
BMC Res Notes.
2014 Jun 21;7:380.
Paper
FULL-TEXT PDF ARTICLE
Prevalence of dyslipidemia among HIV-infected patients using
first-line highly active antiretroviral therapy in Southern
Ethiopia: a cross-sectional comparative group study.
Tadewos A, Addis Z, Ambachew H, Banerjee S.
AIDS
Res Ther. 2012 Oct 25;9(1):31.
Paper
FULL-TEXT
ARTICLE
Dyslipidaemia in HIV-1-infected patients receiving protease
inhibitors after initial treatment with first-line-based
non-nucleoside reverse transcriptase inhibitors: a
cross-sectional study.
Pefura Yone EW, Kengne AP,
Ashuntantang G, et al
BMJ Open.
2012 Aug 8;2(
Paper
FULL-TEXT ARTICLE
HIV
and HAART-Associated Dyslipidemia.
Feeney ER, Mallon PW.
Open Cardiovasc Med J.
2011;5:49-63.
Paper
The Effect of polymorphisms in candidate genes on the Long-Term Risk of
Lipodystrophy
and Dyslipidemia in HIV-infected Caucasians Starting Antiretroviral Therapy.
Marzocchetti A, Schwarz J, DI Giambenedetto S, et al
AIDS Res Hum Retroviruses. 2011 May 20.
Abstract
FULL-TEXT ARTICLE
Dyslipidemia in AIDS patients on highly active antiretroviral
therapy.
Nery MW, Martelli CM, Turchi MD.
Braz J Infect Dis.
2011 Apr;15(2):151-5.
Paper
Dyslipidemia related to antiretroviral
therapy. EstradaV, Portilla J.
AIDS Rev.
2011 Jan-Mar;13(1):49-56.
Abstract |